Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case

被引：0
|
作者：
Yoshimura, Yukihiro [1 ]
Miyata, Nobuyuki [1 ]
Komatsu, Hirokazu [2 ]
Tachikawa, Natsuo [1 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan
[2] Yokohama Municipal Citizens Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
来源：
AIDS | 2018年 / 32卷 / 01期
关键词：
VIVO ANTIVIRAL ACTIVITY; RESISTANCE PROFILE; SHORT-TERM; IN-VITRO; INHIBITOR; PROTEASE; RITONAVIR;
D O I：
10.1097/QAD.0000000000001665
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：127 / 129
页数：3
相关论文
共 50 条
  • [31] A PROSPECTIVE EVALUATION BY PAIRED BIOPSY OF FIBROSIS PROCESSION IN HIV-HCV COINFECTION COMPARED TO HCV MONOINFECTION
    Sterling, R.
    Wegelin, J. A.
    Smith, P. G.
    Luketic, V. A.
    Stravitz, R. T.
    Fuchs, M.
    Puri, P.
    Shiffman, M. L.
    Sanyal, A. J.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S418 - S418
  • [32] LIVER FIBROSIS IN AFRICAN AMERICANS, COMPARING HCV MONO-INFECTION WITH HIV-HCV COINFECTION
    Silver, Dana
    Karnik, Geeta
    Osinusi, Anu
    Silk, Rachel
    Stabinski, Larissa
    Doonquah, Leleka
    Henn, Sarah
    Teferi, Gebeyehu
    Masur, Henry
    Kottilil, Shyam
    Fishbein, Dawn
    HEPATOLOGY, 2011, 54 : 1186A - 1187A
  • [33] Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection
    Brescini, Lucia
    Orsetti, Elena
    Gesuita, Rosaria
    Piraccini, Francesca
    Marchionni, Elisa
    Staffolani, Silvia
    Castelli, Pamela
    Drenaggi, Davide
    Barchiesi, Francesco
    HEPATITIS MONTHLY, 2014, 14 (08)
  • [34] Virologic and immunologic efficacy of tipranavir/ritonavir monotherapy in a HIV-HCV coinfected patient
    Gomez-Rivas, Paula
    Ramon Blanco, Jose
    Obaldia, Carmen
    Antonio Oteo, Jose
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 300 - 300
  • [35] COMPARISON OF FREQUENCIES OF DRUG-DRUG INTERACTIONS BETWEEN SOFOSBUVIR/LEDIPASVIR AND OMBITASVIR/DASABUVIR/PARITAPREVIR/RITONAVIR ± RIBAVIRIN AMONG HIV/HCV COINFECTED PATIENTS
    Schriever, C.
    Ahmed, A.
    Delehanty, K. R.
    Yager, J.
    Farrow, G.
    Kashtan, R.
    Lodise, T.
    Patel, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S801 - S801
  • [36] Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection
    Cooper, C
    MacPherson, P
    Cameron, W
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (01) : 31 - 35
  • [37] A Prospective Evaluation by Paired Liver Biopsy of Fibrosis Progression in HIV-HCV Coinfection Compared to HCV Monoinfection
    Sterling, Richard K.
    Wegelin, Jacob A.
    Smith, Paula G.
    Luketic, Velimir A.
    Stravitz, R. Todd
    Fuchs, Michael
    Puneet, Puri
    Shiffman, Mitchell L.
    Sanyal, Arun J.
    GASTROENTEROLOGY, 2010, 138 (05) : S780 - S780
  • [38] HIV-HCV coinfection: Similar rates of cirrhosis and death than HCV alone, outcomes not averted by HAART
    Monto, Alexander
    Currie, Sue
    Dove, Lorna M.
    Tracy, Daniel
    George, Sally
    Myers, Angela
    Ryan, James C.
    Wright, Teresa L.
    HEPATOLOGY, 2007, 46 (04) : 298A - 298A
  • [39] Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection
    Trimoulet, P
    Neau, D
    Le Bail, B
    Rullier, A
    Winnock, M
    Galperine, T
    Legrand, E
    Schvoerer, E
    Dupon, M
    Ragnaud, JM
    Bioulac-Sage, P
    Chêne, G
    Fleury, H
    Lafon, ME
    JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (02) : 143 - 151
  • [40] THE PREVALENCE AND IMPACT OF HEPATIC STEATOSIS ON RESPONSE TO DAA THERAPY IN HIV-HCV COINFECTION.
    Johnson, Leigh P.
    Sterling, Richard K.
    HEPATOLOGY, 2019, 70 : 964A - 965A
12345